Ongoing pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes ongoing pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Miscarriage · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes miscarriage compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproductive technology
Nonsteroidal anti‐inflammatory drugs showed no clear difference in clinical pregnancy compared with placebo/ no treatment (low certainty).
1 finding from 1 review
Ectopic pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes ectopic Pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Multiple pregnancy · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes multiple pregnancy compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Side effects · assisted reproductive technology
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes side effects compared with placebo/ no treatment (very low certainty).
1 finding from 1 review
Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Unintended effects from treatment · women with endometriosis
It is very uncertain whether NSAID changes unintended effects from treatment compared with placebo (very low certainty).
1 finding from 1 review
Number of women requiring more invasive treatment: not reported · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant satisfaction with treatment: not reported · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events and drug reactions · Subfertile women undergoing in vitro maturation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate per woman · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin showed no clear difference in live birth rate per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher adverse events (gastrointestinal) per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher clinical pregnancy rate per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Menstrual frequency per woman · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin may leads to higher menstrual frequency per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Ovulation rate · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher ovulation rate per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Miscarriage · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin showed no clear difference in miscarriage rate per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review